Biohaven establishes $350M at-the-market equity offering via amended agreement with J.P. Morgan

Biohaven Ltd.

Amendment No. 2 to Equity Distribution Agreement allows up to $350M in common share sales.
J.P. Morgan Securities acts as manager for ATM program on NYSE at prevailing market prices.
New shelf registration (File No. 333-295531) and prospectus supplement filed May 4, 2026.
Proceeds for general corporate purposes; timing and amount depend on market conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.